Home » Newsletters » BioWorld Science

BioWorld Science

May 25, 2005

View Archived Issues

Antiparkinsonian drug hemantane poised to start clinical trials

Update on the therapeutic benefits of anecortave in AMD

OSI-211 plus doxorubicin show promise as palliative therapy for advanced cancer

Antitumor effects reported for ZK-EPO in advanced cancer patients

Product highlights at AEterna Zentaris

UC Irvine awarded NIA grant for Alzheimer's disease

Johnson & Johnson's Risperdal for autism deemed not approvable by FDA

FDA approves extended shelf-life for Taxus Stent System

Ortho-McNeil licenses Cellzome small-molecule technology for Alzheimer's disease research

Progen commences phase II clinical trial of anticancer agent PI-88

Intercell directs E.U. effort in developing novel vaccine against Lyme borreliosis

Praecis reports major restructuring plan

Organon and Lexicon Genetics to codevelop biotherapeutics drugs

Geron cleared by FDA to commence clinical development of telomerase inhibitor for CLL

Tapestry initiates phase I clinical trial of TPI-287 in patients with taxane resistance

FDA grants Arginox cardiogenic shock drug orphan drug designation

CytRx seeks FDA approval to begin phase II clinical trials of ALS drug candidate

Epix submits response to FDA approvable letter for MRI contrast agent

PRECISE trial awaits first futility analysis recommendation

Studies describe activity and pharmacokinetics of regadenoson

Activity of lemuteporfin photodynamic therapy seen in LUTS patients

ZD-6474 combined with androgen ablation adds benefit in prostate cancer model

CNTO-328 demonstrates anticancer activity in animals and humans

Tesaglitazar improves abnormalities in nondiabetic patients with insulin resistance

Investigation of pasireotide progresses

ART-123 effective as postoperative thrombosis prophylaxis

Updated Coreg labeling approved by FDA

New anti-HIV agents described in recent patents

New treatments for type 2 diabetes reported

Novel ophthalmic agents disclosed by the University of Michigan

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...